← Open Payments lookup

REVEL DEGEN: Open Payments

NPI 1841822004 · LUVERNE, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,767 in 194 payments from 15 companies in 2025. Trend: 2023 $1,171 · 2024 $2,558 · 2025 $2,767

Food & beverage: $2,655Education: $111
CompanyPaymentsAmount
ABBVIE INC.37$436
Teva Pharmaceuticals USA, Inc.18$368
Otsuka America Pharmaceutical, Inc.25$336
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$331
Supernus Pharmaceuticals, Inc.21$256
Neurocrine BioSciences, Inc.20$256
Alkermes, Inc.14$206
E.R. Squibb & Sons, L.L.C.15$153
Takeda Pharmaceuticals U.S.A., Inc.9$135
Lundbeck LLC5$80

Products named: VRAYLAR, REXULTI, CAPLYTA, Qelbree, INGREZZA, ARISTADA, UZEDY, COBENFY.

Industry payments across MN — which companies pay providers there.